Bill and Melinda Gates Foundation has awarded a grant of USD 1,999,634 to support identification of novel compounds inhibiting henipavirus replication.
Bill and Melinda Gates Foundation awarded a grant of $898,153 to University of California San Diego to develop an oral prodrug of remdesivir to treat diseases caused by pandemic threat viruses.
Open Philanthropy has awarded a grant of USD 385,000 to support henipavirus antiviral research
Bill and Melinda Gates Foundation has awarded a grant of USD 1,888,128 to support henipavirus antiviral R&D
Bill and Melinda Gates Foundation has awarded a grant of USD 1,931,160 to support development of inhibitors of henipavirus N protein
Bill and Melinda Gates Foundation has awarded a grant of USD 2,261,487 to support structural characterization of the Nipah virus replicase.
Bill and Melinda Gates Foundation has awarded a grant of USD 3,004,907 to support the generation of tools and model systems to study henipavirus replication for antiviral discovery.
Open Philanthropy has awarded a grant of USD $1,020,475 to support the development of assays for henipavirus antiviral research
Bill and Melinda Gates Foundation has awarded a grant of USD 2,791,302 to support development of cell culture and small animal models of Nipah virus replication and pathogenesis.
Open Philanthropy awarded a grant of $195,600 to fund the initial stages of a clinical trial of ramatroban for the suppression of life-threatening symptoms of COVID-19 infections.